Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Able continues to plead guilty in criminal proceedings

Executive Summary

A sixth Able Laboratories manager has pleaded guilty to conspiracy in connection with the defunct firm's fraudulent testing and manufacturing practices, and he has indicated the direct involvement of at least one top executive. The six employees are all from Able's quality control department. In their plea agreements, the former employees describe a "secret project, directed by the highest levels of the company, which included forging data in chemist and laboratory notebooks and binders to obtain [FDA approval]," U.S. attorney Christopher Christie announces in an Aug. 7 press statement. All of Able's products were recalled from the market following multiple violations cited by FDA during good manufacturing practices inspections (1"The Pink Sheet" July 18, 2005, p. 31)...

You may also be interested in...



FDA Cites Able For Failing To Reject Out-Of-Specification Drugs, Altering Data

Able Labs routinely failed to reject drugs that did not meet established standards, specifications and quality control criteria, according to FDA inspectional observations included in a "Form 483" report

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS048659

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel